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Abstract
Aim
To investigate how 1) maternal delivery mode and 2) prematurity in infants are associated
to antibiotic treatment and length of hospital stay.
Methods
Women having given birth and infants 0–12 months discharged from hospital between July
2005 and November 2011 were identified from the Swedish National Patient Register. Med-
ical records were reviewed for 203 women and 527 infants. The risk ratio (RR) between
antibiotic treatment and 1) delivery mode in women; 2) prematurity in infants was calcu-
lated. Length of stay and days of antibiotic therapy were compared by Wilcoxon rank-sum
test.
Results
Women: There was an association between emergency caesarean section (CS) and antibi-
otic treatment (RR 5.0 95% confidence interval (CI) 2.2–11.5), but not for elective CS.
Length of stay was longer for CS (emergency and elective) compared to vaginal delivery
(p<0.01). Infants: RR for antibiotic treatment in preterm compared to term infants was 1.4
(95% CI 1.0–1.9). Length of stay (p<0.01), but not days of therapy (p = 0.17), was higher in
preterm compared to term infants.
Conclusion
We found that emergency CS increased the probability of maternal antibiotic treatment dur-
ing hospitalisation, but no difference was found between term and preterm infants. The
results are well aligned with current guidelines and may be considered in future studies on
the effects of antibiotics.
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Introduction
Antibiotics are commonly used worldwide to treat bacterial infections in children and adults.
In Sweden, one of three patients receive antibiotics during hospitalisation and hospitals
account for 11% of the total national antibiotic use [1]. Information on dispensed antibiotics at
an individual level in outpatient care is available through the Swedish PrescribedDrug register
(SPDR) [2], but there is no equivalent register for inpatient care. Thus, information on the full
individual exposure to antibiotics is currently unavailable. Although antibiotics are essential
for treating serious bacterial infections, extensive use promotes antibiotic resistance and trans-
mission of nosocomial infections [1]. Antibiotics given to the mother peri-partummay affect
the pattern of infection in the child after birth [3] and early life exposure to antibiotics has been
suggested to affect the colonisation of the gut flora and the developing immune system [3, 4].
Long term health consequences that have been linked to antibiotic exposure during fetal and
early life include obesity [5, 6], allergic disease [7, 8] and asthma [8, 9]. However, further stud-
ies are needed to understand the causality and potential confounders affecting these associa-
tions [10, 11].
The average length of stay in Swedish hospitals for women giving birth was 2.2 days for vag-
inal delivery (VD) and 3.7 days for cesarean section (CS) in 2009 [12]. A survey of clinical
guidelines in Swedish obstetric clinics showed that most clinics recommend antibiotic prophy-
laxis for emergency CS (which holds a higher risk of maternal post-partum infection), but not
for elective CS [13]. Antibiotic prophylaxis is used during VD if risk factors for vertical trans-
mission of Group B- Streptococci exist or in pre-labour premature rupture of membranes
(pPROM) in week 22–32, to reduce risk of chorioamnionitis and neonatal infection [14]. Apart
from the knowledge of current guidelines, we are not aware of any previous study that has
investigated the relation between different deliverymodes and the probability of antibiotic
treatment in mothers giving birth
Bacterial infections in infants often present with unspecific symptoms and are difficult to
diagnose, which may lead to both over-treatment and under-treatment with antibiotics [15].
Neonates with clinical symptoms of sepsis are commonly given empirical antibiotic treatment
before confirmation of bacterial origin to prevent mortality in neonatal sepsis [16]. Preterm
infants have a less developed innate immune system than term infants, with an increased risk
for bacterial infections [17]. Furthermore, since maternal infection is one important mecha-
nism contributing to spontaneous preterm births, preterm infants are more likely to be exposed
to pathogens intra-uterine [18]. Preterm infants also have an increased length of stay compared
to term infants [19] and are more often exposed to invasive medical devices during hospitaliza-
tion [17], which increases the risk of nosocomial infections. Thus, it is likely that preterm
infants are treated with antibiotics more frequently than term infants. Previous point preva-
lence studies have reported on general antibiotic use in inpatient care on a national level [20,
21] and we have recently reported proportions of antibiotics treatment with different child-
hood and maternal diagnoses [22], but comparisons between term and preterm birth have not
been performed.
Since antibiotics given during the fetal and early life may affect the infant’s future health, it
is of importance to study how pregnant women and infants are exposed to antibiotics in hospi-
tals in addition to the available information from outpatient care. The aim of this study was to
investigate the association between inpatient antibiotic treatment and deliverymode in preg-
nant women and prematurity in infants. Moreover, we aimed to examine how length of stay
and days of therapy differed between the groups.
Early Life Treatment with Antibiotics in Hospitals
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Patients and methods
Study design and population
This cross-sectional population-based study was based on linkage between registers held by the
National Board of Health andWelfare (NBHW); SPDR, the National Patient Register (NPR)
and the Medical Birth Register (MBR). The Swedish Personal Identity Number (PIN) is a
unique identifier for every resident in Sweden and enables linkage of registers. SPDR contains
information on all prescribed drugs in outpatient care since July 2005, classified according to
the Anatomical Therapeutic Chemical classifications system (ATC). NPR contains national
information on all primary and secondary diagnoses in inpatient care since 1987. MBR was
established in 1973 and includes data on more than 98% of all births in Sweden.
In 2011, a linkage between the NPR and SPDR was performed at the NBHW and a cohort
of all pregnant women and all children 0–5 years with a discharge date in the NPR between 1st
July 2005 and 30th of November 2011 were identified as previously described (24). In this pres-
ent study three groups were selected from the initial cohort for further study, according to
patient’s age and diagnosis in NPR; 1) women with a diagnosis of VD (according to the Inter-
national Classification of Disease, 10th revision (ICD-10): O80), elective CS (O82.0) or emer-
gency CS (O82.1); 2) infants aged 0–12 months at discharge with a primary or secondary
diagnosis of prematurity (ICD-10: P07.2 or P07.3) and 3) infants aged 0–12 months without a
diagnosis of prematurity (i.e. term infants). Pregnancy was defined as the period between the
estimated date of conception and the infants’ birth date, based on information on gestational
age fromMBR. Term infants with a primary diagnosis of malformations or factors influencing
health status (ICD-10 codes Q or Z) were excluded to obtain a healthy reference group. A ran-
dom sample of hospital visits from each group (n = 250 women, n = 640 infants) were drawn
by the NBHW and the patient’s PIN’s were provided. In order to target patients who were
given antibiotics only during the hospitalisation, individuals with a dispensed prescription of
antibiotics in SPDR at the same day or day after the discharge date in NPR were excluded.
Requested medical records
Starting in January 2012, the study participants’ medical records, corresponding to the date of
discharge and PIN, were requested by a letter to the head of the ward where the patient had
been treated. Two reminder letters were sent out before the end of data collection in June 2013.
Each medical record was manually reviewed and all available information regarding diagnosis,
length of stay and potential antibiotic treatment was extracted. The numbers of requested and
receivedmedical records and the final study populations of women and infants are displayed
in Figs 1 and 2. In total, medical records were received for 222 hospital visits for women and
546 hospital visits for infants, which correspond to a response rate of 89% and 85% respec-
tively. Furthermore, thirty-eight hospital visits (19 women and 19 infants) were excluded due
to missing information on antibiotic use, resulting in a final study population of 203 hospital
visits for women and 527 hospital visits for infants.
Variables
Information on women’s and infants’ age at admission and infants’ sex was extracted from the
medical records. In women, age 30–34 years was chosen as reference group since it constituted
the majority of individuals. Preterm infants were categorised as moderately preterm (born
between 28–36 completed gestational weeks, ICD-10: P07.3) and extremely preterm (born
before 28 completed gestational weeks, ICD-10: P07.2). Infant age was categorized as<3
months, 3–5, 6–8 and 9–12 months. Length of stay was defined as the period between date of
Early Life Treatment with Antibiotics in Hospitals
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Fig 1. Study population and medical record request for pregnant women. Medical records were randomly selected from a register-based
cohort of patients treated in Swedish hospitals between July 2005 and November 2011. Abbreviations: NPR = National Patient Register,
MBR = Medical Birth Register, SPDR = Swedish Prescribed Drug Register, ICD-10 = International Classification of Disease 10th revision.
doi:10.1371/journal.pone.0164126.g001
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admission and discharge. Administration of antibiotics was identified in the medical records
by ATC-code J01. Antibiotic treatment was categorised as “yes”, if antibiotics were adminis-
tered at any time during hospitalisation; “no” if antibiotics were not given. “Days of therapy”
Fig 2. Study population and medical record request for infants 0–12 months. Medical records were randomly selected from a
register-based cohort of patients treated in Swedish hospitals between July 2005 and November 2011. Abbreviations: NPR = National
Patient Register, SPDR = Swedish Prescribed Drug Register, ICD-10 = International Classification of Disease 10th revision.
doi:10.1371/journal.pone.0164126.g002
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was defined as the total number of days with any or multiple types of antibiotic treatment. For
each individual, treatment days for all administrations of antibiotics were summed. Individuals
with missing information on both start- and end date, were excluded from the analysis on days
of therapy. If information was missing only for the end date, treatment time for each adminis-
tration was assumed to be one day. Information on start- and end date was complete only in
half of the women treated with antibiotics. Thus, the analysis of days of therapy was only per-
formed among infants.
Statistical analysis
Risk ratio (RR) with 95% confidence intervals (CI) were estimated for antibiotic treatment in
relation to deliverymode and degree of prematurity, according to Cornfield [23]. Since the age
distribution of infants differed considerably between term and preterm infants, sub-analyses
were performed for the age category with the majority of individuals (0–3 months). Descriptive
statistics for length of stay (all individuals) and days of therapy (infants with antibiotic treat-
ment in medical records) were presented in a box plot. Due to skewed distributions, two-sam-
ple Wilcoxon rank-sum test was used for comparisons between groups for length of stay and
days of therapy. Cuzick’s non-parametric test for trend [24] was used to investigate the dose-
response relationship for “term”, “moderately preterm”, and “extremely preterm” infants in
relation to antibiotic treatment, length of stay and days of therapy. Significancewas set at the
5% level. All analyses were performed using Stata statistical software, version 12.
Ethical considerations
Consent to access the medical records was given by the head of each medical department. All
data extracted from the medical records was de-identified prior to analysis and is presented in
an aggregated way where no results may be connected to specific patients. The study has been
approved by the Regional Ethical ReviewBoard in Stockholm, Sweden.
Results
Pregnant women
Table 1 displays antibiotic treatment in relation to deliverymode and age at delivery in preg-
nant women (N = 203). Almost two out of three women who gave birth with emergency CS
(63%) were treated with antibiotics, while less than one in seven women who gave birth by elec-
tive CS (14%) or VD (13%) received antibiotics. Women delivering by emergency CS were thus
five times more likely to receive antibiotics compared to women delivering by VD (RR 5.0, 95%
CI 2.2–11.5), but no significant difference was found when comparing elective CS to VD. The
proportion of women treated with antibiotics in relation to maternal age at delivery varied
between 34% (25–29 years) and 47% (<25 years). However, the difference between age groups
was not statistically significant. Length of stay was significantly higher for both emergency and
elective CS compared to VD (p<0.01) (Fig 3).
Infants
The youngest age group (< 3 months) contained a majority of the infants in the study popula-
tion (55% of the term and 92% of the preterm infants). The number of individuals in each of
the age groups 3–5, 6–8 and 9–12 months decreasedwith increasing age. The majority of both
term (61%) and preterm (59%) infants in the study population were males (data not tabulated).
Table 2 presents antibiotic treatment in infants in relation to prematurity, sex and age at admis-
sion. In total, 22% of all infants were treated with antibiotics at least once during
Early Life Treatment with Antibiotics in Hospitals
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hospitalisation. RR for antibiotic treatment in preterm compared to term infants was 1.4, but
the results did not reach statistical significance (95% CI 1.0–1.9). However, extremely preterm
infants were twice as likely to receive antibiotics compared to term infants (RR 2.4, 95% CI
1.5–3.7) and there was a significant dose-response relationship for “term”, “moderately pre-
term”, and “extremely preterm” infants in relation to antibiotic treatment (p<0.01). There was
no statistically significant association between antibiotic treatment and sex or age among term
Table 1. Risk ratios (RR) and 95% confidence intervals (CI) for antibiotic treatment in relation to delivery mode and maternal age at delivery
(N = 203).
All Antibiotics
N No, n (%) Yes, n (%) RR (95% CI)
Delivery mode Vaginal 40 35 (87.5) 5 (12.5) 1 (ref)
Elective CS 64 55 (85.9) 9 (14.1) 1.1 (0.4–3.1)
Emergency CS 99 37 (37.4) 62 (62.6) 5.0 (2.2–11.5)
Age (years) <25 17 9 (52.9) 8 (47.1) 1.3 (0.7–2.3)
25–29 47 31 (66.0) 16 (34.0) 0.9 (0.6–1.5)
30–34 74 47 (63.5) 27 (36.5) 1 (ref)
>35 65 40 (61.5) 25 (38.5) 1.05 (0.7–1.6)
doi:10.1371/journal.pone.0164126.t001
Fig 3. Boxplot with mean (◆) for length of stay for women by delivery mode. For elective CS, the median is equal to the lower quartile.
Abbreviations: CS = Caesarean section
doi:10.1371/journal.pone.0164126.g003
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or preterm infants. Sub-analyses of antibiotic treatment in infants 0–3 months showed similar
results as in the entire study population, with a small but not statistically significant difference
between term and preterm infants (RR 1.2, 95% CI 0.8–1.8) and a doubled probability of anti-
biotic treatment in extremely preterm infants (RR 2.6, 95% CI 1.6–4.2) (S1 Table).
Fig 4 displays the distribution of length of stay and days of therapy for term, moderately pre-
term and extremely preterm infants. Length of stay was significantly higher in both moderately
and extremely preterm infants compared to term infants (p<0.01), and showed a significant
dose-response relationship (p<0.01). To calculate days of therapy for infants who had received
antibiotics (n = 118), individuals with missing information on start- and end date were
excluded (n = 9). Analysis was performed for the remaining 109 individuals and included 20
individuals (18.3%) where end date was missing and treatment time had been assumed to be
one day. The median for days of therapy was 5 days for both preterm and term infants. No dif-
ference in days of therapy was found between term and preterm infants, neither when treating
prematurity as dichotomous (Wilcoxon rank sum test, p = 0.17) or with degree of prematurity
(Cuzick’s trend test, p = 0.30).
Discussion
We found that women who delivered by emergency CS were five times more likely to receive
antibiotics compared to women who delivered by VD or elective CS. Length of stay was signifi-
cantly higher in women who delivered by CS compared to VD. Although antibiotic treatment
in preterm infants overall did not reach statistical significance compared to term infants,
extremely preterm infants were twice as likely to receive treatment as term infants. Length of
stay was significantly higher in preterm infants compared to term infants, but no difference
could be seen in days of therapy.
The prevalence of maternal antibiotic administration peri-partumvaries globally. Global
surveys performed in non-European countries by theWorld Health Organisation reported that
antibiotics were administered to 47% of VD [25] and 87% of elective and emergency CS [26]. A
Danish cohort study of 750 women found that antibiotics were given to 13% of VD and that
antibiotic prophylaxis was given to all CS [27]. Several countries, such as Canada [28] and the
United Kingdom [29], have implemented national guidelines recommending antibiotic pro-
phylaxis for both elective and emergencyCS. In contrast, our results from Swedish medical rec-
ords suggest that antibiotics are commonly used in emergency CS but not as often in elective
Table 2. Risk ratios (RR) and 95% confidence intervals (CI) for antibiotic treatment by prematurity, sex and age in infants 0–12 months of age.
All Antibiotics
N No, n (%) Yes, n (%) RR (95% CI)
All 527 409 (77.6) 118 (22.4) -
Prematurity Term 259 210 (81.1) 49 (18.9) 1 (ref)
Preterm 268 199 (74.2) 69 (25.8) 1.4 (1.0–1.9)
Moderately 230 178 (77.4) 52 (22.6) 1.2 (0.8–1.7)
Extremely 38 21 (55.3) 17 (44.7) 2.4 (1.5–3.7)
Sex Male 317 251 (79.2) 66 (20.8) 1 (ref)
Female 210 158 (75.2) 52 (24.8) 1.2 (0.9–1.6)
Age (months) <3 389 295 (75.8) 94 (24.2) 1 (ref)
3–5 64 53 (82.8) 11 (17.2) 0.7 (0.4–1.3)
6–8 42 35 (83.3) 7 (16.7) 0.7 (0.3–1.4)
9–12 32 26 (81.2) 6 (18.8) 0.8 (0.4–1.6)
doi:10.1371/journal.pone.0164126.t002
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CS. This is in concordance with the local clinical guidelines from the Swedish Strategic Pro-
gram against Antimicrobial Resistance [14] and a national survey of clinical guidelines [13].
Approximately 22% of the infants in this study received antibiotics during hospitalisation.
Previous point prevalence studies by the Swedish Strategic Program against Antimicrobial
Resistance have reported that an average of 29% of children aged 0–16 years were treated with
antibiotics during hospitalisation [21]. Since we did not include patients who had a dispensed
prescription of antibiotics in SPDR at the same day or day after the discharge, it is reasonable
that we report a lower proportion of antibiotic treatment compared to the point prevalence
study.
A large part of our study population consisted of neonates. Although neonatal sepsis is a rel-
atively uncommon condition (3-4/1000 born children), it can develop rapidly and has a mor-
tality of 9–15% [30]. Neonates with clinical symptoms of sepsis are routinely given empirical
antibiotic treatment, before confirmation of bacterial origin, in order to prevent mortality.
Fig 4. Boxplot with mean (◆) for length of stay and days of therapy for infants by degree of prematurity. Abbreviations: MP = Moderately
premature, EP = Extremely premature
doi:10.1371/journal.pone.0164126.g004
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[16]. Early onset sepsis occurs within 72 hours after birth and the infection is often transmitted
vertically by bacteria in the mother’s urogenital tract or intra-amniotic fluid. Late onset sepsis
which occursmore than 72 hours after birth is acquired by pathogens in the environment [30].
Antibiotic use among neonates in selected hospitals has previously been described in different
prospective cohort studies. For example, Zingg et al found that 26.7% of neonates in Geneva,
Switzerland, were treated with antibiotics for an average of 6.8 days [31], while Cantey et al
found that 72% of the neonates in Texas, US were treated with antibiotics for an average of 5.7
days [32]. However, neither of the studies addressed differences in antibiotic treatment
between term and preterm neonates. Furthermore, due to differences in patient characteristics,
level of health care and demographic factors it is difficult to compare results between single-
center studies.
In our study, extremely preterm infants were twice as likely to receive antibiotic treatment
during hospitalisation compared to term infants, while no significant difference could be seen
betweenmoderately preterm and term infants. As a group, extremely preterm infants have
very high morbidity; half of surviving infants have been estimated to suffer from severe neona-
tal morbidities [33]. In contrast, moderately preterm infants have a health status more like
term infants, which could explain the similar results between these moderately preterm and
term infants.
Håkansson et al studied antibiotic use in neonatal wards on a national level, through the
Swedish Neonatal Quality Register [30]. A strong correlation was seen between days of antibi-
otic therapy and gestational age; days of therapy varied between a mean of 1 day of therapy in
term infants to 37 days of therapy in the extremely premature infants. In contrast, we did not
find a significant difference in days of therapy between term, moderately preterm and
extremely preterm individuals. This could be due to the wider range of age our study covered
(first year of life compared to the neonatal period) and also that we included antibiotic treat-
ment independent of diagnosis, while Håkansson et al focusedmainly on infants with neonatal
sepsis.We observed a difference in age distribution between term and preterm infants in our
study population. This is likely due to the fact that the indications for hospitalisation differ
between term and preterm, since a larger proportion of preterm infants are hospitalised in con-
nection to birth compared to term infants. Since the difference in age between the two groups
could affect our results, sub-analyses were performed for infants 0–3 months. However, the
results did not differ compared to the entire study population.
The strength of our study is the initial cohort of women and infants identified from the
Swedish nation-wide population-based health registers. Since our cohort included all hospital
admissions for the selected diagnoses in Sweden between July 2005 and November 2011, the
risk for selection bias is minimised. Furthermore, the response rate of medical records for both
groups of women and infants was high, which is important for the results to be representative
of the target population. By combining register data with patient data frommedical records, we
were able to study individual antibiotic treatment in relation to deliverymode and prematurity
within hospitals, in a way not previously performed in Sweden.
The study has some limitations. Firstly, we had relatively small sample sizes, resulting in
wide confidence intervals. Our results should therefore be interpreted with caution due to pos-
sible lack of power. Secondly, the reliability of information about antibiotics in the medical rec-
ords could be discussed.Antibiotics were only used in 62% of emergency CS, which is low
considering current guidelines. It is possible that antibiotics may have been given in reality, but
that it was not stated in the discharge summary or included in the provided drug-record.
Thirdly, the information regarding days of therapy was incomplete on several occasions. Our
data included antibiotics given to the woman during the entire time of hospitalisation but due
to lack of information on start and end date of antibiotic exposure, we cannot draw any
Early Life Treatment with Antibiotics in Hospitals
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conclusions regarding if the antibiotics was given peri-partumor post- partum in this group.
Finally, since preterm infants are at a higher risk of exposure to intra-uterine infection due to
chorioamnionitis (34) and pPROM (18) it would have been interesting also to study these con-
ditions; however our sample size was too small.
In conclusion, women delivering by emergency CS had a higher probability of treatment
with antibiotics than other modes of delivery and all CS had an increased length of stay com-
pared to VD. These results confirm current guidelines. Extremely preterm infants were twice
as likely to receive antibiotic treatment compared to term infants. Preterm infants overall were
not more likely to receive antibiotic treatment, although a dose-response trend could be
observed for degree of prematurity. The hospital stay was longer in preterm infants. Since
exposure to antibiotics in early life may be linked to long term health consequences, difference
in antibiotic treatment between the groups may be taken into consideration in future studies
investigating the long term health effects of antibiotic exposure in early life.
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